Anticancer Agents
Start with the big picture
The lesson organizes anticancer drugs by their chemical features and mechanisms. Alkylating agents and platinum complexes damage DNA through cross-links, while antimetabolites disrupt nucleic-acid synthesis after activation. Methotrexate, 5-fluorouracil, cytarabine, and thiopurines illustrate how structural changes and metabolic steps shape activity. Vinca alkaloids and taxanes have opposing effects on microtubules, and topoisomerase inhibitors interfere with enzyme–DNA complexes. Anthracyclines combine DNA intercalation and topoisomerase II inhibition with reactive oxygen species generation. Together, these examples show why understanding functional groups, prodrug activation, and target binding is central to medicinal chemistry. The full lesson also examines selected structural determinants and toxicity-related features.
What you'll learn
- Describe how alkylating agents and platinum complexes form DNA cross-links.
- Explain activation and key target interactions of representative antimetabolites.
- Distinguish the effects of vinca alkaloids and taxanes on microtubules.
- Identify how topoisomerase inhibitors and anthracyclines interfere with DNA-related processes.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.